Third Myron Karon Memorial Lecture. Resistance of human tumors to cancer chemotherapeutic agents: an important research problem
- PMID: 370531
- DOI: 10.1002/mpo.2950050117
Third Myron Karon Memorial Lecture. Resistance of human tumors to cancer chemotherapeutic agents: an important research problem
Abstract
The mechanisms whereby malignant cells become biochemically resistant to anti-cancer drugs are surveyed, with emphasis on human tumors. Methotrexate is used as a model to illustrate the mechanisms of resistance that can occur, and how cells can increase their production of dihyrofolate reductase, the target enzyme. Drug resistance remains one of the major impediments to the successful use of chemotherapy for neoplastic diseases.
Similar articles
-
Methotrexate resistant cells as targets for selective chemotherapy.Adv Enzyme Regul. 1985;24:3-11. doi: 10.1016/0065-2571(85)90066-4. Adv Enzyme Regul. 1985. PMID: 3915186 Review.
-
Fifth Gordon Hamilton-Fairley memorial lecture. Methotrexate resistance and gene amplification: an experimental model for the generation of cellular heterogeneity.Br J Cancer. 1985 Apr;51(4):459-65. doi: 10.1038/bjc.1985.66. Br J Cancer. 1985. PMID: 3978027 Free PMC article.
-
Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.Cancer Res. 1983 Nov;43(11):5286-92. Cancer Res. 1983. PMID: 6225514
-
The fifth Myron Karon Memorial Lecture. The cure of cancer by chemotherapy - reflections on how it happened.Med Pediatr Oncol. 1980;8(2):107-114. doi: 10.1002/mpo.2950080202. Med Pediatr Oncol. 1980. PMID: 6999316 No abstract available.
-
The clinical pharmacology of antineoplastic agents (first of two parts).N Engl J Med. 1975 May 22;292(21):1107-13. doi: 10.1056/NEJM197505222922107. N Engl J Med. 1975. PMID: 124015 Review. No abstract available.
Cited by
-
Saturable process involved in active efflux of vincristine as a mechanism of multidrug resistance in P388 leukemia cells.Pharm Res. 1989 Aug;6(8):690-6. doi: 10.1023/a:1015986405834. Pharm Res. 1989. PMID: 2813261
-
Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.Klin Wochenschr. 1983 Nov 2;61(21):1089-94. doi: 10.1007/BF01496470. Klin Wochenschr. 1983. PMID: 6196516
-
Cytogenetical changes during early stages of development of methotrexate resistance in HeLa cells.Med Oncol Tumor Pharmacother. 1985;2(1):33-8. doi: 10.1007/BF02934778. Med Oncol Tumor Pharmacother. 1985. PMID: 4058076
-
The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells.Cancer Chemother Pharmacol. 1987;19(1):25-9. doi: 10.1007/BF00296250. Cancer Chemother Pharmacol. 1987. PMID: 3815722
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources